Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
163.4 USD | +0.50% | -2.77% | +5.28% |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.37% | 288B | |
+33.18% | 704B | |
+28.59% | 577B | |
-3.77% | 348B | |
+18.37% | 327B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.87% | 147B | |
-7.83% | 145B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie, Genmab Say Phase 1/2 Trial of Epcoritamab in Follicular Lymphoma Patients Showed 82% of Overall Response Rate